Literature DB >> 6304047

Phosphorylation of the (Na,K)-ATPase by a plasma membrane-bound protein kinase in friend erythroleukemia cells.

L A Yeh, L Ling, L English, L Cantley.   

Abstract

A decrease in the activity of the (Na,K)-ATPase is an early and essential step in commitment of Friend virus-infected murine erythroleukemia cells to terminal erythroid differentiation. Plasma membranes from these cells were purified and shown to contain ouabain-inhibitable (Na,K)-ATPase present as approximately 0.4% of the total membrane protein. Protein kinase activity also co-purified with the plasma membrane and preferentially phosphorylated a Nonidet P-40 detergent-extractable 100,000-Da peptide. The 100,000-Da phosphopeptide migrated with the alpha subunit of dog kidney (Na,K)-ATPase when electrophoresis was carried out in the presence of sodium dodecyl sulfate in either 5 or 10% polyacrylamide gels. In two-dimensional gel electrophoresis, it separated into a series of spots between pH 5.1 and 5.4, while dog kidney alpha subunit appeared as a doublet at pH 5.3-5.4. When Nonidet P-40-solubilized plasma membranes were passed through a ouabain affinity column in the presence of Mg2+, Na+, and ATP, the 100,000-Da phosphopeptide was retained and could be eluted by ouabain. This peptide was also phosphorylated in living murine erythroleukemia cells, and proteolysis patterns of the peptide labeled in vitro, the peptide labeled in vivo, and the purified dog kidney alpha subunit using V8 protease were nearly identical. Phosphothreonine was detected in both the peptides labeled in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304047

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Neutral amino acid transport systems in animal cells: potential targets of oncogene action and regulators of cellular growth.

Authors:  M H Saier; G A Daniels; P Boerner; J Lin
Journal:  J Membr Biol       Date:  1988-08       Impact factor: 1.843

2.  The receptor function of the Na+, K+-activated adenosine triphosphatase system.

Authors:  B M Anner
Journal:  Biochem J       Date:  1985-04-01       Impact factor: 3.857

Review 3.  H+-ATPases from mitochondria, plasma membranes, and vacuoles of fungal cells.

Authors:  B J Bowman; E J Bowman
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

4.  Phosphorylation of the Na,K-ATPase by Ca,phospholipid-dependent and cAMP-dependent protein kinases. Mapping of the region phosphorylated by Ca,phospholipid-dependent protein kinase.

Authors:  A V Chibalin; O D Lopina; S P Petukhov; L A Vasilets
Journal:  J Bioenerg Biomembr       Date:  1993-02       Impact factor: 2.945

5.  Monoclonal antibodies distinguish subtypes of retinal horizontal cells.

Authors:  L H Young; J E Dowling
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

6.  Basal phosphatidylinositol turnover controls aortic Na+/K+ ATPase activity.

Authors:  D A Simmons; E F Kern; A I Winegrad; D B Martin
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

Review 7.  The role of AMPK in regulation of Na+,K+-ATPase in skeletal muscle: does the gauge always plug the sink?

Authors:  Sergej Pirkmajer; Metka Petrič; Alexander V Chibalin
Journal:  J Muscle Res Cell Motil       Date:  2021-01-04       Impact factor: 2.698

8.  Isoproterenol stimulates rapid extrusion of sodium from isolated smooth muscle cells.

Authors:  E D Moore; F S Fay
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

9.  Glucagon stimulation of hepatic Na(+)-pump activity and alpha-subunit phosphorylation in rat hepatocytes.

Authors:  C J Lynch; K M McCall; Y C Ng; S A Hazen
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

10.  Hyperthermia, Na+K+ATPase and lactic acid production in some human tumour cells.

Authors:  R H Burdon; S M Kerr; C M Cutmore; J Munro; V Gill
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.